BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Here’s What Makes Nuvation Bio (NUVB) a Smart Investment Pick

  • BioTech Health X
  • November 3, 2026
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Read More
0 Shares
0
0
0
0
0
0
0

Is Wave Life Sciences (WVE) A Smart Long-Term Buy?

  • BioTech Health X
  • November 3, 2026
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Read More
0 Shares
0
0
0
0
0
0
0

Viking Therapeutics (VKTX) Rockets 35.67% as Its Obesity Pipeline Raises the Stakes

  • BioTech Health X
  • November 3, 2026
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Read More
0 Shares
0
0
0
0
0
0
0

Travere (TVTX)’s FILSPARI Sales Jump 96% and Give Its Biotech Story Some Muscle

  • BioTech Health X
  • November 3, 2026
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Read More
0 Shares
0
0
0
0
0
0
0

Here’s Why You Should Consider Investing in NewAmsterdam Pharma (NAMS)

  • BioTech Health X
  • November 3, 2026
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Read More
0 Shares
0
0
0
0
0
0
0

Is it a Wise Move to Invest in Prime Medicine (PRME)?

  • BioTech Health X
  • November 3, 2026
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Read More
0 Shares
0
0
0
0
0
0
0

5 Best Biotech Stocks to Buy According to Billionaires

  • BioTech Health X
  • November 1, 2026
5. Nuvation Bio Inc. (NYSE:NUVB) Number of Hedge Fund Holders — 42 Number of Billionaire Holders — 19…
Read More
0 Shares
0
0
0
0
0
0
0

10 Best Biotech Stocks to Buy According to Billionaires

  • BioTech Health X
  • November 1, 2026
The race to find the next blockbuster medicine has biotech investors studying two price tags: what a treatment…
Read More
0 Shares
0
0
0
0
0
0
0

Ocular Therapeutix (OCUL) Has $598.6M as Its Eye Drug Approaches a Filing Milestone

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Nuvation Bio (NUVB) Drug Sales Climb 25%!

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Taysha (TSHA) Raises $230M for a Gene Therapy Story With Plenty Still to Prove

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Absci (ABSI) Raises $100M as Its AI Hair Loss Treatment Faces the Proof Test

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Savara (SVRA) Has $173M and a November FDA Date That Could Rewrite Its Story

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Maravai (MRVI)’s mRNA Business Grows 37.3%

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Recursion (RXRX) Lands a $10M Milestone as Its AI Drug Discovery Story Gets Real

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

ImmunityBio (IBRX) Sales Jump 121% as Its Cancer Drug Gets a Bigger Playing Field

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Precigen (PGEN) Turns $74.7M in Drug Sales Into a Profit Story Worth Watching

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0

Immatics (IMTX) Has $448M in Cash and a 56% Cancer Response Rate

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Read More
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • 5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
  • Would You Still Dare to Invest in Revolution Medicines (RVMD)?
  • Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Featured Posts
    • November 11, 2026
    10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 11, 2026
    5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 6, 2026
    Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
    • November 6, 2026
    Would You Still Dare to Invest in Revolution Medicines (RVMD)?
    • November 6, 2026
    Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Recent Posts
  • AbbVie (ABBV) Delivers $17.4 Billion in Revenue
    • November 6, 2026
  • Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
    • November 6, 2026
  • Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
    • November 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,187)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top